Our finding suggested that this phenomenon occurred through an activation of TGFβ to reduce proinflammatory and cytokine gene signatures such as CCL8, CCL11, CXCL10, and TNFSF12 leading to immune suppression in patients with CRC. This evidence concerns the gene CXCL10 and colorectal carcinoma.